Inhaled insulin effective long-term
Inhaled insulin maintains glycaemic control and pulmonary function in patients with diabetes even over four years of continuous therapy, according to new research.
A University of Miami study found the rate of overall hypoglycaemia decreased from 2.58 episodes/subject month to 1.50 after four years of treatment using inhaled insulin.
The study looked at 204 patients with type 1 diabetes, insulin-treated type 2 diabetes or type 2 diabetes who had taken part in three month randomised clinical trials for inhaled insulin.
Mean HbA1c was 8.23 after four years in inhaled insulin patients compared with 8.71 at the start of the treatment.